Acquired Thrombotic Thrombocytopenic Purpura After ChAdOx1 nCoV-19 Vaccine: A Case Report

Acquired Thrombotic Thrombocytopenic Purpura After ChAdOx1 nCoV-19 Vaccine: A Case Report

COVID-19, the illness caused by SARS-CoV-2, continues to cause significant morbidity and mortality across the world. An important step in overcoming SARS-CoV-2 is the global vaccination plan. Cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been recently described after SARS-CoV-2 v...

Full description

Saved in:
Bibliographic Details
Main Authors: Domenica Caramazza, Marco Salvini, Vincenzo Saturni, Francesco Ripamonti, Michele Merli, Benedetta Bianchi, Stefania Agnoli, Davide Sirocchi, Barbara Mora, Elena Galfrascoli, Francesco Passamonti
Format: Article
Language:English
Published: American College of Physicians 2022-07-01
Series:Annals of Internal Medicine: Clinical Cases
Online Access:https://www.acpjournals.org/doi/10.7326/aimcc.2021.0110
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.acpjournals.org/doi/10.7326/aimcc.2021.0110

Similar Items